CPA Calls on Trump Administration to Take Strong, Decisive Action to Decouple from China and Strengthen U.S. Industrial Capacity

CPA Calls on Trump Administration to Take Strong, Decisive Action to Decouple from China and Strengthen U.S. Industrial Capacity

The era of global dependency on the CCP is over. For decades, Wall Street, multinational corporations, and globalist institutions helped finance China’s rise at the direct expense of American workers, manufacturers, and national security.

CPA Economist Leads Rare Bipartisan Push to Fix America’s Generic Drug Crisis

CPA Economist Leads Rare Bipartisan Push to Fix America’s Generic Drug Crisis

CPA Economist Andrew Rechenberg gave his testimony and answered questions in a four- panelist hearing. It was arguably the most agreeable hearing in years. A bipartisan consensus on America’s generic drug supply chain is nearly fully formed now.

Pharmaceutical 232 Must Cover Generic Drugs to Fulfill President’s Promise of Reshoring Essential Medicine Production

Pharmaceutical 232 Must Cover Generic Drugs to Fulfill President’s Promise of Reshoring Essential Medicine Production

The Trump administration’s Section 232 investigation into pharmaceutical imports is reportedly close to being final. The final investigation’s success will depend largely on whether or not the Commerce Department determines that there is a crisis in the generics industry — an issue that President Trump highlighted back in 2023.

Tariffs Are Not Causing Inflation: Breaking Down August 2025 CPI

Tariffs Are Not Causing Inflation: Breaking Down August 2025 CPI

The August 2025 inflation report has reignited debate over tariffs. Some pundits have been quick to blame trade policy for rising prices, invoking Smoot-Hawley comparisons and warning of disaster on the scale of the Great Depression. But the data tells a different story.

China Now Producing Dozens of Drugs Below Market Price – Dumping Them Globally is Next Move

China Now Producing Dozens of Drugs Below Market Price – Dumping Them Globally is Next Move

As proof that no company can match China on price, Chinese producers of active pharmaceutical ingredients (APIs) and the key starting materials (KSMs) used to make them are slashing prices by up to 50%. Not even low-cost India – one of the largest importers of Chinese KSMs – can compete at those levels.

Torsekar: Defending America’s Copper Mills Will Take More Than Tariffs

Torsekar: Defending America’s Copper Mills Will Take More Than Tariffs

Data centers powering AI need copper wiring and transformers. EVs use nearly four times more copper than gas-powered cars. Wind turbines, solar farms and the modern electric grid all depend on it. As such, copper is a building block of tomorrow’s economy and the backbone of America’s national security.